Novartis Ag (NVS) Return on Equity [ROE] (2009 - 2026)
Novartis Ag's Return on Equity [ROE] came in at 84.40% for Q2 2026, down 18.81 percentage points from 103.21% a year earlier but up 2.75 percentage points from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2025, Novartis Ag's Return on Equity [ROE] was 30.81%, up 4.53 percentage points from FY2024.
- Return on Equity [ROE] carries a five-year change of +16.42 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was 26.28% in FY2024 (-1.71 pp), 27.98% in FY2023 (+17.05 pp), 10.93% in FY2022 (-27.66 pp) and 38.59% in FY2021 (+24.20 pp).
- The five-year range for quarterly Return on Equity [ROE] is 21.60% (Q3 2021) to 108.68% (Q2 2024).
- Year-over-year, Return on Equity [ROE] has declined for six consecutive quarters, with an average year-over-year change of -8.59 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q4 2023 (a gain of 56.46 percentage points), and the weakest in Q4 2025 (a drop of 30.30 percentage points).
- Business Quant data shows NVS's Return on Equity [ROE] at 81.65% (Q1 2026), 77.94% (Q4 2025) and 76.46% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | - |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 22.24% |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 43.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 84.40% |
| Mar 31, 2026 | 81.65% |
| Dec 31, 2025 | 77.94% |
| Sep 30, 2025 | 76.46% |
| Jun 30, 2025 | 103.21% |
| Mar 31, 2025 | 98.74% |
| Dec 31, 2024 | 108.24% |
| Sep 30, 2024 | 105.84% |
| Jun 30, 2024 | 108.68% |
| Mar 31, 2024 | 100.44% |
| Dec 31, 2023 | 100.14% |
| Sep 30, 2023 | 79.88% |
| Jun 30, 2023 | 66.73% |
| Mar 31, 2023 | 61.13% |
| Dec 31, 2022 | 43.68% |
| Sep 30, 2022 | 53.50% |
| Jun 30, 2022 | 41.88% |
| Mar 31, 2022 | 42.17% |
| Dec 31, 2021 | 43.34% |
| Sep 30, 2021 | 21.60% |
API Access
Novartis Ag Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();